Saturday, October 31, 2020
Mitochondrial Health

#91 – Eric Topol, M.D.: Can AI empower physicians and revolutionize affected person care?

On this episode, Dr. Eric Topol, founder and director of the Scripps Analysis Translational Institute, shares how synthetic intelligences and deep studying is at present impacting drugs and the way it may rework the healthcare trade not solely when it comes to the technological developments, but in addition in restoring the patient-doctor relationship for higher affected person outcomes and experiences. We additionally talk about Eric’s wealthy and interesting profession in cardiology in addition to his involvement as one of many first outspoken researchers to query the cardiovascular security of Vioxx.


We talk about:

  • Eric’s background and his supply of curiosity in cardiology [3:15];
  • The US medical area’s resistance to technological change and studying from different healthcare fashions [11:30];
  • Eric’s mission on the Cleveland Clinic [20:45];
  • How Eric helped to elucidate the problems with Vioxx (and why he got here to remorse it) [30:00];
  • How Eric got here to discovered one of the vital influential analysis facilities on the planet [47:45];
  • How AI and deep studying is at present impacting drugs, and the long run potentialities [56:45];
  • Intestine microbiome—Its position in well being, impression on glycemic response and gas partitioning, and the way deep studying may enhance our analysis and remedy [1:18:00];
  • Why machines mixed with human docs is superior to at least one with out the opposite [1:32:15];
  • How AI and machines can reinstate drugs as a horny profession (and alleviate doctor burnout) [1:37:00];
  • Eric’s dream experiment [1:47:30] and;
  • Extra.


Eric’s background and his supply of curiosity in cardiology [3:15]

  • Eric initially had an curiosity in drugs (endocrinology, particularly) as his father had type 1 diabetes
  • Supposed to do a diabetologist residency at UC San Francisco however was impressed by UCSF heart specialist Dr. Kanu Chatterjee and Eric modified his path
  • Cardiology is a really broad self-discipline with many, many subspecialties
    • The downsided being that the final cardiologists, those who look out for the general cardiovascular well being of the affected person and usually advocate in opposition to pointless procedures, don’t get sufficient “respect”, says Eric

A breakthrough in coronary heart monitoring

  • Eric was a part of the group that realized that sufferers didn’t should be monitored in hospital to get a 12-lead cardiogram
  • In truth, even to today, persons are having to put on a Holter monitor which was created in 1950
  • However we’re getting away from that and Eric sees this because the entry level to a vivid future in wi-fi coronary heart monitoring

“20 years in the past was type of the entry level – the place we simply first devoted wi-fi firm card items – and it’s simply the place we’re going to construct from to in the end eradicate the necessity for many hospital rooms, which is a reasonably large deal and it’s most likely probably the most transformative facet of the place we’re headed as a result of that’s the primary merchandise for healthcare value” – Eric Topol, M.D. 


The US medical area’s resistance to technological change and studying from different healthcare fashions [11:30]

  • The medical area is mostly resistant to alter and it takes longer to undertake one thing new, exemplified by the dearth of embracement of digitalization, which may decrease prices 
  • Change solely happens when it’s tied to markedly improved reimbursement…

{finish of present notes preview}

Would you want entry to intensive present notes and references for this podcast (and extra)?

Check out this post to see an instance of what the substantial present notes appear to be. Grow to be a member immediately to get entry.

Become a Member

Eric Topol, M.D.

Dr. Eric Topol is a heart specialist, geneticist, and digital drugs researcher. Previous to shifting to Scripps in 2006, Eric served as Chairman of cardiovascular drugs on the Cleveland, main it to develop into the primary heart for coronary heart care and was the founding father of a brand new faculty of drugs. At Scripps he was additionally the  founder and serving director of the Scripps Analysis Translational Institute. In 2019, he authored his third e book, Deep Medicine, by which he submits that drugs has develop into void of human connection and argues that AI can empower physicians and revolutionize affected person care. His principal scientific focus has been on the genomic and digital instruments to individualize drugs. Topol was notably awarded an NIH potential analysis grant and to be a lead within the All of US analysis program, which goals to make developments in tailor-made, particular person healthcare.  Eric can be the the editor-in-chief of Medscape. 

Twitter: @EricTopol

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *